Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Deciding to go booze-free, even for a short stint of time, can be a wise decision for our health, our wallets, and even our relationships
Week one through two brings the sharpest fatigue, as the body encounters the metabolic shift for the first time
Set Up Billing Verify your payer contracts cover obesity counseling/medication management Set up CPT codes for E/M visits and obesity counseling (if applicable) Train staff on GLP-1 prior authorization requirements (or use platform automation) Consider cash-pay pricing structure for patients without coverage 5
This dual action enhances insulin secretion, lowers glucagon levels, and slows gastric emptying, resulting in reduced appetite and increased feelings of fullness
Retatrutide is an unapproved investigational triple agonist (GLP-1, GIP, glucagon receptors) not licensed by the MHRA, EMA, or FDA for routine clinical use
We recognize that most people don't have six months to a year to fight with an insurance company
US$ 24.74
US$ 23.91
US$ 21.65
US$ 28.86
US$ 27.83
US$ 23.61
